Serum immunosuppressive acidic protein as a potent prognostic factor for patients with metastatic renal cell carcinoma

被引:8
|
作者
Igarashi, T [1 ]
Tobe, T [1 ]
Kuramochi, H [1 ]
Akakura, K [1 ]
Ichikawa, T [1 ]
Hamano, S [1 ]
Suzuki, N [1 ]
Furuya, Y [1 ]
Ito, H [1 ]
机构
[1] Chiba Univ, Sch Med, Dept Urol, Chuo Ku, Chiba 2608670, Japan
关键词
immunosuppressive acidic protein; renal cell carcinoma; metastatic; survival rates; cutoff level;
D O I
10.1093/jjco/hye004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Estimation of survival probability of individual patients with metastatic renal cell carcinoma was difficult owing to diverse prognostic factors. We analyzed serum immunosuppressive acidic protein (IAP) levels and the cutoff value, then tested its validity for assessing patients' prognoses. Methods: Serum IAP was measured longitudinally in 84 patients with metastatic disease. Before therapy, cutoff levels of IAP were tested every 20 mug/ml between 600 and 1200 mug/ml. The prognostic importance of IAP and its cutoff level was estimated. Results: The cutoff level of IAP was set at 800 mug/ml for 40 patients who had metastatic disease with the primary tumor in situ and for 44 patients with recurrent disease. IAP was found to be a significant prognostic factor for both patient groups. Conclusions: Serum IAP is an important prognostic factor for patients with metastatic renal cell carcinoma. Stratification of patients according to prognosis is feasible using the cutoff level.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 50 条
  • [41] Is abnormal coagulation a possible prognostic factor for efficacy of immunotherapy in metastatic renal cell carcinoma patients?
    Madzhuga, A.
    Tsimafeyeu, I.
    Demidov, L.
    Somonova, O.
    Yelizarova, A.
    THROMBOSIS RESEARCH, 2007, 120 : S165 - S166
  • [42] Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib
    Beuselinck, Benoit
    Vano, Yann-Alexandre
    Oudard, Stephane
    Wolter, Pascal
    De Smet, Robert
    Depoorter, Lore
    Teghom, Corine
    Karadimou, Alexandra
    Zucman-Rossi, Jessica
    Debruyne, Philip R.
    Van Poppel, Hendrik
    Joniau, Steven
    Lerut, Evelyne
    Strijbos, Michiel
    Dumez, Herlinde
    Paridaens, Robert
    Van Calster, Ben
    Schoffski, Patrick
    BJU INTERNATIONAL, 2014, 114 (01) : 81 - 89
  • [43] Prognostic impact of C-reactive protein response in patients with metastatic renal cell carcinoma
    Saito, Kazutaka
    Tatokoro, Manabu
    Limura, Yasumasa
    Fujii, Yasuhisa
    Akai, Yasuyuki
    Koga, Fumitaka
    Kobayashi, Tsuyoshi
    Kawakami, Satoru
    Kihara, Kazunori
    JOURNAL OF UROLOGY, 2008, 179 (04): : 167 - 168
  • [44] Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma
    F Wittke
    R Hoffmann
    J Buer
    I Dallmann
    K Oevermann
    S Sel
    T Wandert
    A Ganser
    J Atzpodien
    British Journal of Cancer, 1999, 79 : 1182 - 1184
  • [45] Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma
    Wittke, F
    Hoffmann, R
    Buer, J
    Dallmann, I
    Oevermann, K
    Sel, S
    Wander, T
    Ganser, A
    Atzpodien, J
    BRITISH JOURNAL OF CANCER, 1999, 79 (7-8) : 1182 - 1184
  • [46] Anemia in patients ≥ 75 years with metastatic clear cell renal cell carcinoma: an important poor prognostic factor in the international metastatic renal cell carcinoma database consortium model
    Ryuichi Mizuno
    Yota Yasumizu
    Nobuyuki Tanaka
    Toshikazu Takeda
    Shinya Morita
    Kazuhiro Matsumoto
    Takeo Kosaka
    Hiroshi Asanuma
    Mototsugu Oya
    BMC Urology, 24
  • [47] Anemia in patients ≥ 75 years with metastatic clear cell renal cell carcinoma: an important poor prognostic factor in the international metastatic renal cell carcinoma database consortium model
    Mizuno, Ryuichi
    Yasumizu, Yota
    Tanaka, Nobuyuki
    Takeda, Toshikazu
    Morita, Shinya
    Matsumoto, Kazuhiro
    Kosaka, Takeo
    Asanuma, Hiroshi
    Oya, Mototsugu
    BMC UROLOGY, 2024, 24 (01)
  • [48] Prognostic role of immunosuppressive acidic protein in patients with esophageal cancer
    Kogure, M.
    Kashimura, S.
    Matsuyama, S.
    Ohtani, S.
    Saze, Z.
    Odashima, Y.
    Saitoh, T.
    Soeta, N.
    Osuka, F.
    Hoshino, Y.
    Saito, T.
    Terashima, S.
    Terashima, M.
    Gotoh, M.
    DISEASES OF THE ESOPHAGUS, 2008, 21 (03) : 214 - 219
  • [49] PREOPERATIVE SERUM ALKALINE PHOSPHATASE LEVEL IS AN INDEPENDENT PROGNOSTIC FACTOR FOR PATIENTS WITH RENAL CELL CARCINOMA
    Klatte, Tobias
    Waldert, Matthias
    Seemann, Christoph
    de Martino, Michela
    Weibl, Peter
    Marberger, Michael
    Remzi, Mesut
    JOURNAL OF UROLOGY, 2010, 183 (04): : E482 - E482
  • [50] Preoperative Serum Cystatin C as an Independent Prognostic Factor for Survival in Patients with Renal Cell Carcinoma
    Ma, Hui
    Wang, Peipei
    Hou, Zhao
    Zhou, Huiyu
    Lv, Dingyang
    Cui, Fan
    Shuang, Weibing
    JOURNAL OF CANCER, 2024, 15 (18): : 5978 - 5985